hepatic alveolar echinococcosis
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Preoperative diagnosis of hepatic alveolar echinococcosis by abdominal ultrasound and/or abdominal CT; 2. Aged 14 to 60 years; 3. Preoperative liver function Child grade A or B; 4. The lesion was confined to the hemihepatic region, and the healthy liver had sufficient compensatory volume; 5. Number of hepatic veins invaded by lesions <=2; 6. The lesion did not invade the inferior vena cava; 7. The number of lesions invading portal vein <=1 branch; 8. The lesion did not invade the diaphragm; 9. No distant metastasis of the lesion occurred in brain or lung; 10. The lesion size should not exceed 10 cm; 11.PNM stage P1~2N0~1MO 12. No serious organic diseases of heart, lung or brain, American anesthesiology society grade i-iii; 13. Subjects are able to understand the study contents of this project and voluntarily sign the informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients refused to participate in the clinical trial; 2. Unwilling to undergo hepatectomy for various reasons; 3. Surgical contraindication and intolerance; 4. Primary liver diseases complicated with cirrhosis and liver cancer; 5. Complicated with malignant tumors of other organs, or with a history of liver metastasis of malignant tumors of other organs; 6. Patients with a history of hepatectomy; 7. Transfer to open for various reasons during the operation; 8. Postoperative pathology confirmed that it was not hepatic alveolar echinococcosis; 9. Poor patient compliance, or failure to adhere to visitors for various reasons, or pregnant and nursing women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss, incision size, intraoperative blood transfusion amount, whether intraoperative lesions residue, postoperative exhaust time, postoperative liquid diet for the first time for the first time time, ambulation, for the first time after time, postoperative pain, for the first time tolerance time, postopera; | — |
Secondary
| Measure | Time frame |
|---|---|
| Operation time, operation cost, total cost of hospitalization; | — |
Countries
China
Contacts
The State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia